Parkinson's Biotech, AI Funding, IPOs
Kilder
- Endpoints: A Parkinson's biotech debut, fundraising campaign and licensing deal
- STAT: STAT+: A biotech hedge fund births a new immunology company
- STAT: New startup to test psychedelic-like drug against Parkinson’s symptom - STAT
- GEN: Mithrl Raises $20M to Expand Deployment of Its Biomedical World Model Across Biopharma
- GEN: Sartorius and NIBRT Partner on Intensified and Continuous Bioprocessing Training Center - Genetic Engineering and Biotechnology News
- GEN: Brain Protein in Mice Offers Insights Into Brain Development and ADHD - Genetic Engineering and Biotechnology News
- BioSpace: Biopharma hiring hotspots: States, disciplines where demand is highest
- Endpoints: Electra's $350M IPO will help it become a commercial biotech
- BioPharma Dive: Electra amasses $350M in biotech’s latest big IPO
- STAT: STAT+: A Sellas immunotherapy study, long delayed, will end in failure
- Raps: Recon: Senate hearing set for FDA nominee; Novo partners with Anthropic for AI drug development - RAPS
- STAT: New startup to test psychedelic-like drug against Parkinson’s symptom - STAT
- wikimedia: Photo by Steve Jurvetson from Los Altos, USA / Wikimedia Commons / CC BY 2.0
Oppsummeringen og talen er laget med KI. Kildelenkene viser opphavet og er ikke en anbefaling av TellMe fra mediene.